Name | Number of supported studies | Average coverage | |
---|---|---|---|
cardiac muscle cell | 5 studies | 35% ± 4% |
Insufficient scRNA-seq data for expression of TRIM63 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 39% | 150.19 | 707 / 1809 | 89% | 86.40 | 418 / 472 |
eye | 0% | 0 | 0 / 0 | 100% | 132.67 | 80 / 80 |
muscle | 100% | 92079.14 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.73 | 1 / 1 |
heart | 100% | 10305.02 | 859 / 861 | 0% | 0 | 0 / 0 |
bladder | 67% | 699.71 | 14 / 21 | 14% | 0.55 | 72 / 504 |
uterus | 54% | 265.01 | 91 / 170 | 15% | 6.96 | 68 / 459 |
thymus | 6% | 16.86 | 37 / 653 | 54% | 2.23 | 328 / 605 |
kidney | 26% | 65.38 | 23 / 89 | 18% | 9.59 | 160 / 901 |
prostate | 14% | 85.17 | 34 / 245 | 10% | 1.62 | 52 / 502 |
pancreas | 2% | 4.08 | 7 / 328 | 19% | 0.32 | 34 / 178 |
breast | 8% | 32.51 | 38 / 459 | 8% | 0.18 | 92 / 1118 |
adipose | 14% | 35.82 | 163 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 9% | 55.67 | 135 / 1445 | 3% | 0.09 | 5 / 183 |
tonsil | 0% | 0 | 0 / 0 | 11% | 1.30 | 5 / 45 |
lung | 6% | 64.58 | 32 / 578 | 6% | 0.16 | 64 / 1155 |
brain | 1% | 3.61 | 37 / 2642 | 7% | 0.15 | 46 / 705 |
adrenal gland | 0% | 1.41 | 1 / 258 | 7% | 0.19 | 17 / 230 |
intestine | 5% | 13.45 | 49 / 966 | 2% | 0.04 | 12 / 527 |
stomach | 4% | 13.44 | 16 / 359 | 2% | 0.03 | 6 / 286 |
liver | 2% | 4.23 | 4 / 226 | 3% | 1.20 | 14 / 406 |
ovary | 2% | 2.98 | 3 / 180 | 3% | 0.12 | 14 / 430 |
blood vessel | 4% | 43.65 | 57 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 4% | 81.30 | 37 / 929 | 0% | 0 | 0 / 0 |
spleen | 2% | 4.79 | 5 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0014732 | Biological process | skeletal muscle atrophy |
GO_0007165 | Biological process | signal transduction |
GO_0045820 | Biological process | negative regulation of glycolytic process |
GO_0016567 | Biological process | protein ubiquitination |
GO_0051384 | Biological process | response to glucocorticoid |
GO_0014878 | Biological process | response to electrical stimulus involved in regulation of muscle adaptation |
GO_0006936 | Biological process | muscle contraction |
GO_0070555 | Biological process | response to interleukin-1 |
GO_0010614 | Biological process | negative regulation of cardiac muscle hypertrophy |
GO_0031430 | Cellular component | M band |
GO_0030018 | Cellular component | Z disc |
GO_0005874 | Cellular component | microtubule |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0031432 | Molecular function | titin binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | TRIM63 |
Protein name | E3 ubiquitin-protein ligase TRIM63 (EC 2.3.2.27) (Iris RING finger protein) (Muscle-specific RING finger protein 1) (MuRF-1) (MuRF1) (RING finger protein 28) (RING-type E3 ubiquitin transferase TRIM63) (Striated muscle RING zinc finger protein) (Tripartite motif-containing protein 63) |
Synonyms | RNF28 MURF1 SMRZ IRF |
Description | FUNCTION: E3 ubiquitin ligase. Mediates the ubiquitination and subsequent proteasomal degradation of CKM, GMEB1 and HIBADH. Regulates the proteasomal degradation of muscle proteins under amino acid starvation, where muscle protein is catabolized to provide other organs with amino acids. Inhibits de novo skeletal muscle protein synthesis under amino acid starvation. Regulates proteasomal degradation of cardiac troponin I/TNNI3 and probably of other sarcomeric-associated proteins. May play a role in striated muscle atrophy and hypertrophy by regulating an anti-hypertrophic PKC-mediated signaling pathway. May regulate the organization of myofibrils through TTN in muscle cells. . |
Accessions | ENST00000374272.4 [Q969Q1-1] Q969Q1 |